SWM
SPPI

SeaCrest Wealth Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

SeaCrest Wealth Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-20,000
Closed -$47K – 587
2020
Q1 		$47K Buy
+20,000
New +$54.7K 0.01% 498

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SeaCrest Wealth Management's SPPI Position: Q2 2020 in Review

SeaCrest Wealth Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2020, closing a stake of 20,000 shares — an estimated $47K sold.

SeaCrest Wealth Management first reported a position in SPPI in Q1 2020 and held it in 1 quarter. The position peaked at $47K in Q1 2020. 158 funds tracked by Wall St. Rank hold SPPI as of Q2 2020.

  • SeaCrest Wealth Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • SeaCrest Wealth Management sold 20,000 Spectrum Pharmaceuticals Inc shares in Q2 2020, an estimated $47K.
  • SeaCrest Wealth Management first reported a position in Spectrum Pharmaceuticals Inc in Q1 2020 and held it in 1 quarter.
  • SeaCrest Wealth Management's Spectrum Pharmaceuticals Inc position peaked at $47K in Q1 2020.
  • 158 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2020.

Based on SeaCrest Wealth Management's 13F filing for Q2 2020, filed 27 Jul 2020.